Daniel Ontaneda

Department of Biomedical Engineering, Cleveland Clinic

Research Area

Biography

Daniel Ontaneda has not added Biography.
If you are Daniel Ontaneda and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 22	2019

Other Publications

Article	Year
Management of acute exacerbations in multiple sclerosis. Annals of Indian Academy of Neurology\| PubMed ID: 20182574	2009
Intracranial atherosclerosis as a risk factor for ischemic stroke during open heart surgery. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association\| PubMed ID: 20471859	2010
Multiple sclerosis: new insights in pathogenesis and novel therapeutics. Annual review of medicine\| PubMed ID: 21888515	2012
Potential mechanisms of efficacy and adverse effects in the use of fingolimod (FTY720). Expert review of clinical pharmacology\| PubMed ID: 22114884	2011
Metabolic syndrome in small fiber sensory neuropathy. Journal of clinical neuromuscular disease\| PubMed ID: 22361523	2011
Early tolerability and safety of fingolimod in clinical practice. Journal of the neurological sciences\| PubMed ID: 23040960	2012
Multiple sclerosis treatment: risk mitigation. Continuum (Minneapolis, Minn.)\| PubMed ID: 23917104	2013
Is neuromyelitis optica with advanced age of onset a paraneoplastic disorder? The International journal of neuroscience\| PubMed ID: 24111490	2014
Sensitivity to volatile anesthetics in patients with dementia: a case-control analysis. Canadian journal of anaesthesia = Journal canadien d'anesthesie\| PubMed ID: 24764187	2014
Benefits versus risks of latest therapies in multiple sclerosis: a perspective review. Therapeutic advances in drug safety\| PubMed ID: 25083243	2012
Risk stratification and mitigation multiple sclerosis. Multiple sclerosis and related disorders\| PubMed ID: 25221744	2014
Experience with fingolimod in clinical practice. The International journal of neuroscience\| PubMed ID: 25271798	2015
Identifying the start of multiple sclerosis injury: a serial DTI study. Journal of neuroimaging : official journal of the American Society of Neuroimaging\| PubMed ID: 25370339	2014
Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives. The Lancet. Neurology\| PubMed ID: 25772899	2015
Progressive multiple sclerosis. Current opinion in neurology\| PubMed ID: 25887766	2015
Risk Mitigation Strategies for Adverse Reactions Associated with the Disease-Modifying Drugs in Multiple Sclerosis. CNS drugs\| PubMed ID: 26407624	2015
Camptocormia and Pisa syndrome as manifestations of acute myasthenia gravis exacerbation. Journal of the neurological sciences\| PubMed ID: 26671078	2015
Propensity methods for multiple sclerosis: The devil is in the details. Multiple sclerosis (Houndmills, Basingstoke, England)\| PubMed ID: 27411702	2016
Relapse rates in patients with multiple sclerosis treated with fingolimod: Subgroup analyses of pooled data from three phase 3 trials. Multiple sclerosis and related disorders\| PubMed ID: 27456887	2016
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis. Contemporary clinical trials\| PubMed ID: 27521810	2016
Heterogeneous depression trajectories in multiple sclerosis patients. Multiple sclerosis and related disorders\| PubMed ID: 27645367	2016
Measuring Brain Tissue Integrity during 4 Years Using Diffusion Tensor Imaging. AJNR. American journal of neuroradiology\| PubMed ID: 27659189	2017
Imaging as an Outcome Measure in Multiple Sclerosis. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics\| PubMed ID: 27699722	2017
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - Commentary. Multiple sclerosis (Houndmills, Basingstoke, England)\| PubMed ID: 27729553	2017
The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nature reviews. Neurology\| PubMed ID: 27834394	2016
Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function. Lancet (London, England)\| PubMed ID: 27889191	2017
Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 12-month follow-up. Multiple sclerosis and related disorders\| PubMed ID: 27919497	2016
Smokers with MS have greater decrements in quality of life and disability than non-smokers. Multiple sclerosis (Houndmills, Basingstoke, England)\| PubMed ID: 28059618	2017
The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics\| PubMed ID: 28770481	2017
Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm. Multiple sclerosis (Houndmills, Basingstoke, England)\| PubMed ID: 28820013	2018
T1-/T2-weighted ratio differs in demyelinated cortex in multiple sclerosis. Annals of neurology\| PubMed ID: 28833377	2017
Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 24-month follow-up. Multiple sclerosis journal - experimental, translational and clinical\| PubMed ID: 28890796	2017
The challenges and opportunities of multiple sclerosis care in Latin America. Multiple sclerosis journal - experimental, translational and clinical\| PubMed ID: 28979792	2017
Clinical outcome measures for progressive MS trials. Multiple sclerosis (Houndmills, Basingstoke, England)\| PubMed ID: 29041863	2017
Stem cell injection-induced glioneuronal lesion of the cauda equina. Neurology\| PubMed ID: 29476035	2018
Treating primary-progressive multiple sclerosis: potential of ocrelizumab and review of B-cell therapies. Degenerative neurological and neuromuscular disease\| PubMed ID: 30050376	2017
Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centers. Neurology. Clinical practice\| PubMed ID: 30140580	2018
Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study. The Lancet. Neurology\| PubMed ID: 30143361	2018
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis. The New England journal of medicine\| PubMed ID: 30157388	2018
Automated Integration of Multimodal MRI for the Probabilistic Detection of the Central Vein Sign in White Matter Lesions. AJNR. American journal of neuroradiology\| PubMed ID: 30213803	2018
Identifying a new subtype of multiple sclerosis. Neurodegenerative disease management\| PubMed ID: 30215581	2018
Treatment decisions in MS: Shifting the goal posts or changing how we see them? Multiple sclerosis (Houndmills, Basingstoke, England)\| PubMed ID: 30234433	2018
Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the US. Multiple sclerosis and related disorders\| PubMed ID: 30368221	2019
Clinical commentary on "Warts and all: Fingolimod and unusual HPV associated lesions". Multiple sclerosis (Houndmills, Basingstoke, England)\| PubMed ID: 30427261	2018
Multiple sclerosis risk factors contribute to onset heterogeneity. Multiple sclerosis and related disorders\| PubMed ID: 30529925	2019
MS progression is predominantly driven by age-related mechanisms - NO. Multiple sclerosis (Houndmills, Basingstoke, England)\| PubMed ID: 30747571	2019
Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS. Neurology\| PubMed ID: 30787160	2019
MOG-related disorders: A new cause of imaging-negative myelitis? Multiple sclerosis (Houndmills, Basingstoke, England)\| PubMed ID: 30931813	2019
Exploratory MRI measures after intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis. Multiple sclerosis journal - experimental, translational and clinical\| PubMed ID: 31236284	2019